Feasibility Study of Anatomical Modeling for Image Guided Thoracic Surgery
This clinical trial assesses the feasibility of creating a 3 dimensional (D) model of the lung and lung nodule(s) from computed tomography (CT) scan images performed during lung surgery. Unlike solid organs (like the kidney, brain, and liver), the lung changes shape (they inflate when a person breathe in and collapse when they breathe out). This makes it difficult to predict where, exactly, the tumor(s) will be on the lungs during surgery. A 3D model may help surgeons better predict where the location of the tumor(s) will be during surgery.
Ask AI to explain this studyKey things to know
This describes the study’s primary purpose.
The study team can explain what participation involves.
These are broad labels—not an eligibility decision.
Checked against the public recordLast updated Oct 28, 2024 · Source: ClinicalTrials.gov
Ask the study team to confirm whether enrollment is open.
Interventional
Locations may change over time.
Study sponsor
What this study is about
- Purpose
- Health Services Research
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- M.D. Anderson Cancer Center
- Interventions being studied
- Procedure: Computed Tomography; Procedure: Therapeutic Conventional Surgery
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.
- Patients must have previous CT images demonstrating a lung mass or masses amenable to lung resection (open or minimally invasive)
- Patient is scheduled for surgical resection in a room equipped with intraoperative CT
- Patient must sign informed consent, with risks and benefits of CT imaging explained
- Patients with lung tumors \>= 1cm to =\< 3 cm based on preoperative CT scan. (Patients with lung tumors from \< 1 cm or \> 3 cm will be reviewed and approved for inclusion on an individual assessment by clinical collaborators)
- Pediatric patients less than 18 years of age
- Patients who have undergone previous ipsilateral thoracic surgery, sclerotherapy, or radiation therapy as intraoperative adhesions may limit lung collapse intraoperatively
- Patients who received neoadjuvant immunotherapy
- Women who are pregnant or nursing
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- M D Anderson Cancer CenterHouston, Texas
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Oct 28, 2024. Always confirm current availability with the study team.